JP2024539080A5 - - Google Patents

Info

Publication number
JP2024539080A5
JP2024539080A5 JP2024523274A JP2024523274A JP2024539080A5 JP 2024539080 A5 JP2024539080 A5 JP 2024539080A5 JP 2024523274 A JP2024523274 A JP 2024523274A JP 2024523274 A JP2024523274 A JP 2024523274A JP 2024539080 A5 JP2024539080 A5 JP 2024539080A5
Authority
JP
Japan
Prior art keywords
expression
progenitor cells
pharmaceutical product
glial progenitor
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539080A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/047083 external-priority patent/WO2023069482A1/en
Publication of JP2024539080A publication Critical patent/JP2024539080A/ja
Publication of JP2024539080A5 publication Critical patent/JP2024539080A5/ja
Pending legal-status Critical Current

Links

JP2024523274A 2021-10-20 2022-10-19 グリア前駆細胞を若返らせることによってミエリン欠乏症を処置するための組成物及び方法 Pending JP2024539080A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163257827P 2021-10-20 2021-10-20
US63/257,827 2021-10-20
US202263350039P 2022-06-08 2022-06-08
US202263350041P 2022-06-08 2022-06-08
US202263350042P 2022-06-08 2022-06-08
US63/350,042 2022-06-08
US63/350,041 2022-06-08
US63/350,039 2022-06-08
PCT/US2022/047083 WO2023069482A1 (en) 2021-10-20 2022-10-19 Compositions and methods for treating myelin deficiency by rejuvenating glial progenitor cells

Publications (2)

Publication Number Publication Date
JP2024539080A JP2024539080A (ja) 2024-10-28
JP2024539080A5 true JP2024539080A5 (cg-RX-API-DMAC7.html) 2025-10-14

Family

ID=84359179

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024523274A Pending JP2024539080A (ja) 2021-10-20 2022-10-19 グリア前駆細胞を若返らせることによってミエリン欠乏症を処置するための組成物及び方法
JP2024523275A Pending JP2024539081A (ja) 2021-10-20 2022-10-19 転写因子の抑圧によってcnsグリア集団を若返らせるための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024523275A Pending JP2024539081A (ja) 2021-10-20 2022-10-19 転写因子の抑圧によってcnsグリア集団を若返らせるための方法及び組成物

Country Status (6)

Country Link
US (4) US20230190961A1 (cg-RX-API-DMAC7.html)
EP (2) EP4419679A1 (cg-RX-API-DMAC7.html)
JP (2) JP2024539080A (cg-RX-API-DMAC7.html)
AU (2) AU2022369984A1 (cg-RX-API-DMAC7.html)
CA (3) CA3234634A1 (cg-RX-API-DMAC7.html)
WO (3) WO2023069484A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230190961A1 (en) 2021-10-20 2023-06-22 University Of Rochester Compositions and methods for treating myelin deficiency by rejuvenating glial progenitor cells
IL319917A (en) * 2022-10-19 2025-05-01 Univ Rochester Methods and compositions for renewing glial populations of the central nervous system with expression of the transcription factor BCL11A

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US275794A (en) 1883-04-10 Eugene ward
US748529A (en) 1903-09-03 1903-12-29 Troy Laundry Machinery Co Ltd Marking-machine.
US5872005A (en) 1994-11-03 1999-02-16 Cell Genesys Inc. Packaging cell lines for adeno-associated viral vectors
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US20030104526A1 (en) 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
WO2002088346A2 (en) 2001-05-01 2002-11-07 National Research Council Of Canada A system for inducible expression in eukaryotic cells
US20030223972A1 (en) 2002-02-15 2003-12-04 Goldman Steven A. Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
US20040029269A1 (en) 2002-05-07 2004-02-12 Goldman Steven A Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
CA2580515C (en) 2004-10-04 2017-05-02 National Research Council Of Canada Expression system, components thereof and methods of use
PT2816112T (pt) 2009-12-10 2018-11-20 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
US20150362508A1 (en) 2013-01-30 2015-12-17 Benaroya Research Institute At Virginia Mason Effector t cell rsistance
US12522594B2 (en) 2017-02-09 2026-01-13 Deutsches Krebsforschungszentrum 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
US12303549B2 (en) 2018-06-21 2025-05-20 University Of Rochester Methods of treating or inhibiting onset of Huntington's disease
AU2019342741B2 (en) * 2018-09-19 2025-12-11 Lineage Cell Therapeutics, Inc. Methods for differentiating pluripotent stem cells in dynamic suspension culture
EP3923962A2 (en) * 2019-02-13 2021-12-22 University of Rochester Gene networks that mediate remyelination of the human brain
EP4099993A4 (en) 2020-02-06 2024-03-13 Emerald Health Pharmaceuticals Inc. COMPOSITION AND METHOD FOR TREATING AND PREVENTING CARDIAC, LUNG, SKIN AND KIDNEY FIBROSIS
IL311610A (en) 2021-09-21 2024-05-01 Scribe Therapeutics Inc Engineered CASX suppressor systems
US20230241118A1 (en) 2021-10-20 2023-08-03 University Of Rochester Rejuvenation treatment of age-related white matter loss
US20230190961A1 (en) 2021-10-20 2023-06-22 University Of Rochester Compositions and methods for treating myelin deficiency by rejuvenating glial progenitor cells

Similar Documents

Publication Publication Date Title
Ginn et al. Gene therapy clinical trials worldwide to 2023—an update
Matharu et al. Modulating gene regulation to treat genetic disorders
JP7591847B2 (ja) デュシェンヌ型筋ジストロフィーに関連するエクソンスプライシングエンハンサー、sgRNA、遺伝子編集ツールおよび使用
JP2023529315A (ja) 機能的aavカプシドのハイスループット工学操作
JP2021502060A5 (cg-RX-API-DMAC7.html)
CN112996913B (zh) 寡聚核酸分子及其应用
Azzouz Gene Therapy for ALS: progress and prospects
CN113164624B (zh) 恢复人类快乐木偶综合征中父系ube3a基因表达的组合物和方法
US20160108402A1 (en) Methods for diagnosing and treating learning or mental disorders
JP2025513066A5 (cg-RX-API-DMAC7.html)
US20240238447A1 (en) Compositions and methods for modulating payload expression at a transcriptional level
JP2024539081A5 (cg-RX-API-DMAC7.html)
KR101779775B1 (ko) 간세포 성장인자의 둘 이상의 이형체를 이용한 근위축성 측삭 경화증 예방 또는 치료용 조성물
JP2023506842A5 (cg-RX-API-DMAC7.html)
Wu et al. The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies
JP2023525476A5 (cg-RX-API-DMAC7.html)
US20220081690A1 (en) Use of mir-204 inhibitor to increase nurr1 protein expression
Velinov Gene therapy for Fragile X Syndrome, challenges, and promises
CN115702246A (zh) 调节性核酸序列
Yadav et al. Vector-Mediated Delivery of Transgenes and RNA Interference-Based Gene Silencing Sequences to Astrocytes for Disease Management: Advances and Prospectives
JP2024542015A5 (cg-RX-API-DMAC7.html)
IL301747A (en) Dlx2 vector
Palacios-Reyes et al. Williams' neural stem cells: new model for insight into microRNA dysregulation
CN114931652B (zh) 一种Hmga2基因在修复受损视网膜中的应用
US20230121720A1 (en) Diagnostic methods using pcg-1a expression